A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.
Kelley KC, Grossman KF, Brittain-Blankenship M, Thorne KM, Akerley WL, Terrazas MC, Kosak KM, Boucher KM, Buys SS, McGregor KA, Werner TL, Agarwal N, Weis JR, Sharma S, Ward JH, Kennedy TP, Sborov DW, Shami PJ.
Kelley KC, et al. Among authors: kennedy tp.
BMC Cancer. 2021 May 7;21(1):510. doi: 10.1186/s12885-021-08242-4.
BMC Cancer. 2021.
PMID: 33957901
Free PMC article.
Clinical Trial.